Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?

Ítems similars

• Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with RA?
  per: Hider, S, et al.
  Publicat: (2003)
• Preliminary study for predicting better methotrexate efficacy in Japanese patients with rheumatoid arthritis
  per: Hashiguchi, Masayuki, et al.
  Publicat: (2016)
• Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis
  per: Hoekstra, M, et al.
  Publicat: (2003)
• Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab
  per: Burmester, Gerd R, et al.
  Publicat: (2017)
• Methotrexate: Optimizing the Efficacy in Rheumatoid Arthritis
  per: Braun, Jürgen
  Publicat: (2011)